Rep. MCCRAVY proposes the following Amendment No.     to H.4100 as introduced by Ways & Means

(Doc Name COUNCIL\DG\4100C003.NBD.DG21.DOCX):

EXPLANATION:

Amend the bill, as and if amended, Part IB, Section 117, GENERAL PROVISIONS, page 515, paragraph 117.133, by striking lines 4-10 and inserting:

/ 117.133.(GP: Medical Marijuana Research) With funds provided in this fiscal year, the University of South Carolina College of Pharmacy and the Medical University of South Carolina are authorized, to the extent permitted by and in accordance with federal laws and regulations, to undertake the following actions: acquire pharmaceutical grade marijuana, marijuana extracts, semi-pure isolates, and purified compounds, including, but not limited to, THC, CBD, CBO, cannabinol, and cannabigerol for use in research and clinical trials to develop potential therapeutic agents for epilepsy, Dravet's Syndrome, chronic pain, cancer, reduction of nausea, and vomiting induced by chemotherapy, glaucoma, obesity, multiple sclerosis, drug abuse, inflammation, and autoimmune disorders, including encephalomyelitis. However, no funds may be expended to acquire any products containing THC./

Amend totals and titles to conform.